Clear market notes built around the JSE, the rand, and what matters locally.

2026-10-12 07:04 • The Motley Fool Positive Axe Cap view: Neutral

ARK Invest has purchased approximately 1.3 million Rocket Lab shares since late August as the stock trades 55% below its May record high. ARK is betting on a future launch shortage by 2030 that Rocket Lab's unflown Neutron rocket could address. While Rocket Lab shows strong demand with a $2.36 billion backlog, the company faces accelerating cash burn ($110 million in Q2) and uncertainty around Neutron's launch timeline, with the stock trading at 44x sales.

Axe note: Cathie Wood keeps buying Rocket Lab despite its steep drop and big questions around its future.

2026-10-12 05:15 • The Motley Fool Positive Axe Cap view: Selective

The article examines six ETFs with strong historical track records and projects potential 20-year growth from $500 monthly investments. It emphasizes the power of long-term investing and compound returns, presenting bull, base, and bear case scenarios for each ETF based on past performance data.

Axe note: A look at six top US ETFs, their potential returns, and practical implications for JSE investors.

2026-10-12 03:20 • The Motley Fool Positive Axe Cap view: Selective

Ethena (ENA) and NEAR Protocol (NEAR) are positioned for significant growth in 2026 and beyond. Ethena's synthetic dollar token USDe generates substantial reserve yields and has approved revenue buybacks once supply reaches $7.5B, with analyst price targets of $0.42 by end-2026 and $2 by end-2028. NEAR's Intents protocol enables efficient cross-chain asset swapping, generating $1.9M in protocol revenue monthly, and has attracted institutional interest with Bitwise launching a NEAR ETF and forecasting a 2030 base case of $155 per token.

Axe note: Ethena and NEAR Protocol offer growth potential, yet South African investors must weigh currency risks and limited local exposure.